Explore the Agenda
7:20 am Chair’s Opening Remarks
Pharma Business Development Insights: Strategic Priorities & Deal Trends for Future Collaborations & Investment to Drive Disease Modification
Moderated by:
7:30 am Pharma Icebreaker Discussion: From Fear of Better to Fear of Missing Out, Pharma’s Strategic Priorities Across Neuroscience
- Comparing sentiment towards neuroscience deal-making, including: which stage of development is most appealing, which modalities are of interest, and what are the key elements of differentiation?
- Discussing data expectations to open a discussion. Guidance on data package and biomarker preferences seen as most credible or promising to generate interest for a deal decision
- Providing the best advice on what is expected when approaching any partner, understanding how to differentiate decks in crowded and sharing insights into types of interactions around early-stage and pre-IND
8:15 am Short Comfort Break to Arrange Organized Networking Session
Networking Session: For Early Introductions & Breaking the Ice with Pharma
8:30 am Pharma Matchmaking Tables: Introductions to Pharma
What is this session?
- With a high concentration of relevant companies in one place, the pharma icebreaker tables offer a guaranteed opportunity for face-to-face interactions. Whether you’re connected on the one-to-one partnering system or not, this is a protected opportunity to introduce yourself and your organization
How is this organized?
- Two weeks out from the conference, pharma will review attending biotech and biotech will review attending pharma, with both making selections to meet with companies they haven’t scheduled meetings with yet and are working in areas of strategic interest
- With these selections, we will build a schedule of company rotations through each pharma’s table, across 90 minutes
10:15 am Morning Break & Networking Opportunity
10:30 am One-on-One Partnering Private Meetings Scheduled
Meeting acceptance rate is a key KPI for a conference’s productivity. To ensure the meeting acceptance rate is as high as possible, we coordinate your 1-to-1 meeting schedule based on your wishlist of connections pre-event.
We coordinate meeting requests. We confirm times. We secure meeting tables. And we place meetings straight into your Outlook.
No cold outreach, no chasing, no waiting for message replies. All the heavy lifting was done on your behalf to secure confirmed, private parenting meetings.
Novel Modalities: Where will There be Efficacy?
11:10 am How Advanced Are New Modalities? Where Are the Fields Opening Up?
- Summarizing the field’s progress across disease areas, including the state of play of different modalities. How do you innovate beyond existing MoAs?
- Considerations for the right modality: working with more established technologies versus promising new pharmacokinetics
11:40 am Positioning Early Phase CNS Trials for Investor Success
- Rethinking early phase strategy for pivotal trial success
- Expanding first-in-human to generate early proof-of-concept
- Smarter protocol design: upfront investment, timelines and downstream ROI
12:10 pm Lunch Break & Networking Opportunity
12:15 pm One-on-One Partnering Private Meetings Scheduled
1:30 pm Showcase Your Science: Pipeline Innovation Partner Presentations
What is this session?
At the intersection of innovative research and business conversations, this forum facilitates the pitching of biotech pipelines and platforms to pharma and investors.
How does this session work?
As you register, secure one of the 15-minute presentation slots available in this presentation session. There will be no conflicting content happening to ensure a full and engaged audience listening to your presentation. We will add your talk to this brochure and on our website to showcase your differentiation in the best light, and host your company description and logo on the website as a company at the forefront of innovation.
1:30 – NIDB-3101: A Biparatopic Tau Antibody Binding Broadly & Neutralizing Tau Seeding Activity Using Alzheimer’S Disease Brains Presented by Discoveric bio alpha & gamma
1:45 – Neurodawn: A Commercial-Stage Biotech – CNS Portfolio, Multi-Asset Clinical Progress & Global Partnering Opportunities Presented by Neurodawn
2:00 – Presentation by KeifeRx
2:15 – Assemblify: Data-driven in bio Modelling for CNS therapeutics Presented by Assemblify
2:30 pm Afternoon Break & Formal Networking Opportunity
2:30 pm One-on-One Partnering Private Meetings Scheduled
3:15 pm Showcase Your Science: Pipeline Innovation Partner Presentations
2nd Presentation Session
Present your company’s slides by securing a 15-minute presentation slot in front of the attending audience.
What is this session?
To host as many innovative companies as possible on day one, this second session opens more presenting opportunities in front of the attending audience.
Presentation Sessions Remaining
3.15 – Tinostamustine, a Novel Approach for the Treatment of Central Nervous System Cancers Presentation by Imbrium Therapeutics
3.30 – Improved BBB Transport via Novel AAV Capsid Engineered to Bind to TfR1 Receptor Presentation by Exegenesis Bio
3.45 – The Opportunity for Neflamapimod in Age-Related Brain Disorders Presentation by CervoMed
4.00 – NUZ-001: An Investigational Oral Therapy in Phase 2/3 Clinical Development for ALS by Neurizon
4.15 – Reimagining Levodopa Therapy with Minitablets & the OraFID Device by Navamedic
4.30 – Risvodetinib as a Potential Disease Modifying Therapy for Neurodegenerative Disease by ABLi Therapeutics
4.45 – Presentation by Agene Bio
5.00 – Presentation by Senovia Bioscience
5.15 – MM-3001: A Fast-Onset, Long-Acting Therapeutic SLiP for Chronic Pain by Mimetic Medicines
Innovating Access: Structuring Smart Collaborations in Drug Delivery
5:30 pm Understanding Latest Thinking Around Drug Delivery: What is Coming Next?
- How has advancing clinical validation increased deal-making across drug delivery technologies?
- Structuring discussions with tech innovators to understand how best to combine modalities
- Balancing developing a naked asset for a larger partnership versus partnering with a delivery technology to develop
6:00 pm End of Conference Day One
6:00 pm Afternoon Drinks Reception & Networking
“People work with people”. Enjoy an informal networking drinks reception with all attending colleagues to catch up, candidly network, initiate, and nurture business relationships built before or during the conference so far.
Hosted by: